Anonymous ID: e3a9af Jan. 10, 2022, 7:05 a.m. No.15343305   🗄️.is đź”—kun   >>3310 >>3320 >>3406 >>3662 >>3761 >>4006

>>15343293

Thousands of Pounds of Ground Beef Sold at Major Retailers Recalled for Possible E. Coli Contamination

January 9, 2022

 

iStock

OREGON – (FDA) – Interstate Meat Dist. Inc., a Clackamas, Ore., establishment, isrecalling approximately 28,356 pounds of ground beef products that may be contaminated with E. coli O157:H7, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today.

 

The raw, ground beef items were produced on Dec. 20, 2021. The products subject to recall and the labels can be viewed here.

 

 

The products subject to recall bear establishment number “EST. 965” inside the USDA mark of inspection or printed next to the time stamp and use or freeze by date. These items were shipped to retail locations in Arizona, California, Nevada, Oregon, Utah, Washington and Wyoming.

 

The issue was reported to FSIS after a retail package of ground beef was purchased and submitted to a third-party laboratory for microbiological analysis and the sample tested positive for E. coli O157:H7. FSIS conducted an assessment of the third-party laboratory’s accreditation and methodologies and determined the results were actionable.

 

Anyone concerned about an illness should contact a healthcare provider. E. coli O157:H7 is a potentially deadly bacterium that can cause dehydration, bloody diarrhea and abdominal cramps 2–8 days (3–4 days, on average) after exposure the organism. While most people recover within a week, some develop a type of kidney failure called hemolytic uremic syndrome (HUS). This condition can occur among persons of any age but is most common in children under 5-years old and older adults. It is marked by easy bruising, pallor, and decreased urine output. Persons who experience these symptoms should seek emergency medical care immediately.

 

FSIS is concerned that some product may be in consumers’ refrigerators or freezers. Consumers who have purchased these products are urged not to consume them. These products should be thrown away or returned to the place of purchase.

 

FSIS routinely conducts recall effectiveness checks to verify recalling firms notify their customers of the recall and that steps are taken to make certain that the product is no longer available to consumers. When available, the retail distribution list(s) will be posted on the FSIS website at www.fsis.usda.gov/recalls.

 

FSIS advises all consumers to safely prepare their raw meat products, including fresh and frozen, and only consume ground beef that has been cooked to a temperature of 160 °F. The only way to confirm that ground beef is cooked to a temperature high enough to kill harmful bacteria is to use a food thermometer that measures internal temperature, https://www.fsis.usda.gov/safetempchart.

 

Consumers and members of the media with questions about the recall can contact Sales Manager Mike Sinner and Quality Assurance Manager Rodolfo Mendoza, Interstate Meat Dist., Inc., at (503) 656-6168.

 

Consumers with food safety questions can call the toll-free USDA Meat and Poultry Hotline at 1-888-MPHotline (1-888-674-6854) or live chat via Ask USDA from 10 a.m. to 6 p.m. (Eastern Time) Monday through Friday. Consumers can also browse food safety messages at Ask USDA or send a question via email to MPHotline@usda.gov. For consumers that need to report a problem with a meat, poultry, or egg product, the online Electronic Consumer Complaint Monitoring System can be accessed 24 hours a day at https://foodcomplaint.fsis.usda.gov/eCCF/.

 

https://breaking911.com/thousands-of-pounds-of-ground-beef-sold-at-major-retailers-recalled-for-possible-e-coli-contamination/

Anonymous ID: e3a9af Jan. 10, 2022, 7:10 a.m. No.15343340   🗄️.is đź”—kun

>>15343310

 

PHA-12292021-01

PUBLIC HEALTH ALERT

IMPORT VIOLATION

Español

ACTIVE

WED, 12/29/2021 - CURRENT

FSIS Issues Public Health Alert for Ineligible Imported Meat and Poultry Products from China

 

WASHINGTON, Dec. 29, 2021 - The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is issuing a public health alertfor an undetermined amount of imported meat and poultry products from China. A recall was not requested because FSIS has been unable to identify and contact the importers. The total amount of ineligible product is undetermined because the investigation is ongoing.

The products subject to the public health alert and labels are listed here.

 

The meat and poultry products do not identify an eligible establishment number on their packaging and were not presented to FSIS for import reinspection.These products are ineligible to import into the U.S., making them unfit for human consumption.

 

The problem was identified through an investigation with U.S. Customs and Border Protection (CBP) and USDA’s Animal and Plant Health Inspection Service (APHIS). FSIS will continue working with CBP and APHIS on the ongoing investigation.

Retailers who have purchased the products are urged not to sell them. Consumers who purchased the products should not consume them and need to dispose of them properly. Consumers are asked to dispose of the products by double bagging them to reduce the possibility of animals accessing the products.USDA cannot confirm whether the products were properly heated to control pathogens that affect domestic livestock.

 

There have been no confirmed reports of adverse reactions due to consumption of these products. Anyone concerned about an illness should contact a health care provider.

 

Consumers with food safety questions can call the toll-free USDA Meat and Poultry Hotline at 1-888-MPHotline (1-888-674-6854) or live chat via Ask USDA from 10 a.m. to 6 p.m. (Eastern Time) Monday through Friday. Consumers can also browse food safety messages at Ask USDA or send a question via email to MPHotline@usda.gov. For consumers that need to report a problem with a meat, poultry, or egg product, the online Electronic Consumer Complaint Monitoring System can be accessed 24 hours a day at

 

https://www.fsis.usda.gov/recalls-alerts/fsis-issues-public-health-alert-ineligible-imported-meat-and-poultry-products-china

 

The problem is they wont label if meat cones from China. Its amazing the number of recalls out there

Anonymous ID: e3a9af Jan. 10, 2022, 7:25 a.m. No.15343397   🗄️.is đź”—kun

>>15343382

If they wanted to keep it secret, they shouldn’t have done a YouTube video.Bragging about it, they just think the public wont make a connection

 

Jack Posobiec Tangerine

@JackPosobiec

He gave a lecture on it at the APA

 

youtube.com

Using Social and Behavioral Science to Support COVID 19 Pandemic…

1:41 AM · Jan 10, 2022·Twitter for iPhone

 

https://twitter.com/JackPosobiec/status/1480429284762304515?s=20

Anonymous ID: e3a9af Jan. 10, 2022, 7:37 a.m. No.15343447   🗄️.is đź”—kun

A High-Risk Medical Device Didn’t Meet Federal Standards. The Government Paid Millions for More

For years after federal inspectors found serious problems with the HeartWare heart pump, agencies like the Department of Veterans Affairs and Centers for Medicare & Medicaid Services continued paying to implant it in patients.

 

Neil BediJan. 7, 5 a.m. EST

 

In 2014, when the Food and Drug Administration found serious problems with a life-sustaining heart pump, its warning letter to the manufacturer threatened to notify other federal health agencies about the inspection’s findings.

 

But for years, no such alert ever went out. Instead, the agency added the warning letter to an online database alongside thousands of others, following its typical procedures, an FDA spokesperson said.

 

Agencies such as the Centers for Medicare & Medicaid Services and the U.S. Department of Veterans Affairs went on paying to implant the HeartWare Ventricular Assist Device, or HVAD, in new patients even though federal inspectors had found problems with the device linked to patient deaths and injuries.

 

Taxpayer dollars continued to flow to the original device maker, HeartWare, and then to the company that acquired it in 2016, Medtronic, for seven years while the issues raised in the warning letter remained unresolved.

 

If crucial safety information in FDA warning letters doesn’t make it to other arms of the government responsible for deciding which medical devices to pay for, experts said patients are the ones put at risk.

 

“It’s clearly a breakdown of communication,” said Dr. Rita Redberg, a cardiologist at the University of California San Francisco who researches medical device safety and regulation. “It’s not just the money, obviously. It’s people’s lives.”

 

The FDA acknowledged that it doesn’t directly notify other agencies when it issues warning letters, pointing instead to its online database, which is accessible to both government officials and the public. “The FDA’s decisions are intended to be patient-centric with the health and safety of device users as our highest priority,” the agency spokesperson said in an email.

 

The HeartWare letter was removed from the public database about two years ago, even though the problems remained unresolved and patients were still receiving implants. The database clears out letters that are more than five years old.

 

CMS, which oversees the Medicare and Medicaid programs, would not say why it continued paying for a device that didn’t meet government standards. It directed questions about the HeartWare warning letter to the FDA. “CMS does not have oversight of the manufacturing and related safety assessments of a medical device manufacturer,” a spokesperson said in an email.

 

The spokesperson noted that CMS requires heart pump patients to have specialized medical teams managing their care, which should monitor FDA communications regarding safety of devices.

 

CMS doesn’t track data on devices by manufacturer, so it’s essentially impossible to calculate its total spending on HVADs. One 2018 medical journal study found that Medicare and Medicaid paid for more than half the cost of all heart pump implants from 2009 to 2014. If that rate of spending continued, CMS may have spent more than $400 million on implanting HVADs since 2014.

 

A spokesperson for the VA said his agency was never notified about the HeartWare warning letter. The VA paid HeartWare and Medtronic more than $3 million after the FDA issued the letter in 2014. It offered this explanation for why: “It’s important to note that FDA Warning Letters are notifications issued to manufacturers found to be in significant violation of federal regulations. They are not product recalls.”

 

In the case of the HVAD, the FDA’s failure to make sure its warning reached beyond the manufacturer may have had life-and-death consequences….

 

In June, Medtronic ended sales and implants of the device, citing new data that showed patients with HVADs had a higher rate of deaths and strokes than those with a competing heart pump.

 

Medtronic declined to comment for this story. It has previously said it believed that after the 2014 warning letter the benefits of the HVAD still outweighed the risks for patients with severe heart failure.

 

Experts said the lack of communication between federal agencies when serious device problems are found is baffling but not surprising. It fits a broader trend of device regulators focusing more on evaluating new products than monitoring the ones already on the market.

 

Its all about the kickbacks

 

https://www.propublica.org/article/a-high-risk-medical-device-didnt-meet-federal-standards-the-government-paid-millions-for-more

Anonymous ID: e3a9af Jan. 10, 2022, 7:47 a.m. No.15343502   🗄️.is đź”—kun   >>3522

>>15343477

HHS, Medicare and Medicaid Services are more corrupt than the CCP, they designed to the payments to hospitals under Covid and under Trump.Seema Vermin and Alex Azaar intensionally undermined POTUS. I’m sure of this, that is why hospitals are continuing to kill people

Anonymous ID: e3a9af Jan. 10, 2022, 7:56 a.m. No.15343541   🗄️.is đź”—kun

>>15343522

 

Explain please

 

ICD-10-CM Codes › Z00-Z99 Factors influencing health status and contact with health services › Z20-Z29 Persons with potential health hazards related to communicable diseases › Z28- Immunization not carried out and underimmunization status › 2022 ICD-10-CM Diagnosis Code Z28.20

2022 ICD-10-CM Diagnosis Code Z28.20

Immunization not carried out because of patient decision for unspecified reason

 

2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code POA Exempt

Z28.20 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

Short description: Immuniz not crd out bec patient decision for unsp reason

The 2022 edition of ICD-10-CM Z28.20 became effective on October 1, 2021.

This is the American ICD-10-CM version of Z28.20 - other international versions of ICD-10 Z28.20 may differ.

 

he following code(s) above Z28.20 contain annotation back-references that may be applicable to Z28.20:

Z00-Z99 Factors influencing health status and contact with health services

Z28 Immunization not carried out and underimmunization status

Approximate Synonyms

Declines tdap vaccination

Declines zoster vaccination

Herpes zoster vaccination declined

Human papillomavirus vaccination declined

Influenza vaccination declined

Patient declines human papilloma virus (hpv) vaccination

Patient declines influenza vaccination

Patient declines strep pneumonia vaccination

Patient declines vaccination

Pneumococcal vaccination declined

Tetanus, diphtheria and acellular pertussis vaccination declined

Vaccine refused by patient

Present On Admission

Z28.20 is considered exempt from POA reporting.

ICD-10-CM Z28.20 is grouped within Diagnostic Related Group(s) (MS-DRG v39.0):

795 Normal newborn

951 Other factors influencing health status

Convert Z28.20 to ICD-9-CM

 

Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)

2017 (effective 10/1/2016): No change

2018 (effective 10/1/2017): No change

2019 (effective 10/1/2018): No change

2020 (effective 10/1/2019): No change

2021 (effective 10/1/2020): No change

2022 (effective 10/1/2021): No change

Diagnosis Index entries containing back-references to Z28.20:

Immunization - see also Vaccination

not done (not carried out) Z28.9

because (of)

unspecified patient reason Z28.20

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Anonymous ID: e3a9af Jan. 10, 2022, 7:59 a.m. No.15343554   🗄️.is đź”—kun

>>15343535

Well at people had much better coverage previously, now it really is a scam, ACA increased the cost of basic from $190 for a young guy to $500 monthly for comparable plan, anf no doctors in network

Anonymous ID: e3a9af Jan. 10, 2022, 8:31 a.m. No.15343687   🗄️.is đź”—kun

>>15343477

Had to remove links

The problem is all these fines are pennies to them

Boston Scientific loses $309 million judgment in Mirowski patent war

UPDATED Sept. 25, 2014, with comment from Boston Scientific.

Boston Scientific (NYSE:BSX) lost a $309 million judgment today in its long-running patent war with the family of the late physician who helped invent the implantable cardioverter defibrillator, Dr. Michel Mirowski.

 

https://www.massdevice.com/boston-scientific-loses-309-million-judgment-mirowski-patent-war/?amp

 

DECEMBER 18, 20174:50 PMUPDATED 4 YEARS AGO

Boston Scientific loses bid to toss whistleblowers' billing claims

By Nate Raymond

A federal judge has rejected a Boston Scientific Corp unit’s bid to dismiss part of a lawsuit alleging it submitted false claims to Medicare for replacement parts for an implantable spinal cord stimulator used to treat chronic pain.

U.S. District Judge John Vazquez in Newark, New Jersey on Friday rejected Boston Scientific Neuromodulation Corp’s contention that the evidence in the case supported dismissing claims in the lawsuit that it violated the False Claims Act.

 

Boston Scientific Hit With $27M Loss in Vaginal Mesh Trial

November 14, 2014 — Reuters reports that Boston Scientific has been ordered to pay $26.7 million to four women who were injured by the company’s Pinnacle vaginal mesh implant, after a jury in Miami, Florida decided the device was defective.

The Pinnacle is designed to be implanted in the center of a woman’s pelvis, where it supports sagging abdominal organs and prevents pelvic organ prolapse.

This is not the first time Boston Scientific has lost a trial involving its vaginal mesh products. Earlier this year, a jury in Texas awarded $73 million to a woman injured by its Obtryx mesh product, though it was slashed to $34.6 million.

Manufacturers of vaginal mesh are facing about 60,000 lawsuits from women who were injured. Several have offered settlements in thousands of lawsuits. Last month, C.R. Bard paid $21 million to settle 500 lawsuits, for about $43,000 per claim.

In a similar agreement, Endo International paid about $48,000 per claim to resolve 10,000 lawsuits. These base payments could be much higher for women who had severe complications or needed revision surgery.

Boston Scientific

Edited By Kevin Connolly

This page features 20 Cited Research Articles

Last Modified: March 30, 2021

FACT CHECKED

Boston Scientific is a Massachusetts-based medical device company with a focus on noninvasive treatment – primarily of cardiovascular, respiratory, neurological, digestive, urological and pelvic conditions. Its first major product was an angioplasty balloon for cardiovascular treatments, introduced in the late-1970s. By 2017, the company had developed more than 13,000 medical products marketed in 100 countries around the world.

 

Its business structure is built around these sectors: cardiovascular, rhythm management (cardiac management and electrophysiology), and MedSurg, or medical and surgical (endoscopy, urology, pelvic health, and neuromodulation – a form of central nervous system treatment).

 

Boston Scientific experienced significant financial and litigation issues in the mid-2000s that continued to affect its bottom line for most of a decade. By the mid-2010s, the company was believed to have turned a corner through restructuring of the organization and addressing legal claims from individuals and the federal government through a series of high profile settlements.

 

By 2015, Boston Scientific claimed that a doctor used one of its devices every 16 seconds to treat peripheral artery disease and a patient was treated every 21 seconds with one of its urology products.

 

But Boston Scientific has recalled some of its products, sometimes in what the U.S. Food and Drug Administration (FDA) has categorized as Class I recalls. These are “situations in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.”

Anonymous ID: e3a9af Jan. 10, 2022, 9:06 a.m. No.15343880   🗄️.is đź”—kun

joshua steinman (🇺🇸,🇺🇸)

He knew

https://t.co/FnM2CZY9cF

Nixon: “The unhappiest people in the worlld are in…”

https://twitter.com/JoshuaSteinman/status/1480417896350117888?s=20